Navigate Digital & Social Innovation, Policy Shifts & Public Expectations With Compliant, Credible & Measurable Strategies Which
Deliver Future-Focused Communications Excellence For Pharma & Healthcare & Strengthen Reputation, Engagement & Trust
08.30 Registration, Informal Networking & GIC Welcome
OPENING REMARKS
09.00 Morning Co-Chairs’ Opening Remarks
Carla Martinez, Associate Director Of External Corporate Communications, Almirall
Marina Moustaka, Director, International Medical Communications, Allergan Aesthetics – AbbVie
PUBLIC TRUST IN PHARMA
DOUBLE PERSPECTIVE
09.10 Elevate & Maintain Crucial Public Trust Through Clear & Credible Dialogue That Tackles Rising Scepticism & Inspires Confidence
- Enhance pharma’s reputation by engaging both internal and external audiences, fostering trust, and ensuring compliance while adapting to a rapidly changing ecosystem
- Master new and strategic communication tactics to counter scepticism and rebuild public confidence in the safety, effectiveness, and credibility of medicines and vaccines
- Navigate the complexities of drug research and pricing transparency through clear messaging that builds understanding and trust in pharma’s commitment to patient outcomes
- Delve into the trust equation by analysing what it takes to build public confidence in pharma’s use of personal data and how responsible, transparent data practices can become a driver of credibility and long-term trust
09.10 Perspective 1
Michael McLean, Global Medical Director, Rheumotalogy, GSK
09.30 Perspective 2
Lillian Auberson, Director Medical Information International, Medical Affairs & Evidence Generation, argenx
AI STRATEGIES – PROVEN INSIGHTS & PRACTICAL IMPLEMENTATION
PANEL Q&A
09.50 AI In Action: Deep Dive Into Exactly How AI Can Streamline Operations, Enhance Communications & Drive Targeted Engagement In Pharma
- Cut through the hype! Learn how AI can be deployed effectively with real-world examples of workflow automation to optimise operations, boost delivery speed, and free up teams for high-impact strategic work
- Recognise misinformation, and emotional disengagement risks tied to AI-generated content, and discover new strategies to address these challenges while preserving audience trust and the authenticity of your communications
- Discover how AI can contribute to clinical trials through smarter patient identification, innovative trial design, and integrated evidence generation to shorten timelines and improve outcomes
- Engage patients and HCPs with precision by leveraging AI-driven insights to tailor messaging, personalise content, and deliver communications that truly resonate across diverse audiences
Shruti Bose, Head of Campaigns, Group Communications, Roche
Ossama Ibrahim, Global Marketing Excellence Director, Merck
Luke Mircea-Willats, Senior Director, International Communications, Moderna
Kayhan Binazir, Director, Vaccines Scientific Communications, GSK
Stanley Mekkattu, Director – Strategic Communications, Global Drug Development & Specialty Generics, Sandoz
REPUTATION MANAGEMENT
KEYNOTE
10.20 Master Reputation Management To Build Trust In Pharma & Strengthen Long-Term Brand Confidence
- Tackle the trust deficit head-on! Reframe innovation through a reputational lens and help position pharma as a force for societal good, balancing access and affordability with the long-term scientific progress
- Align your scientific and economic contributions with national priorities and regain control of the narrative and strengthen public trust
- Strengthen corporate reputation in a fragmented environment by integrating data credibility with authentic storytelling and explore new ways to communicate not just what you do, but why it matters, to reinforce brand integrity and stakeholder confidence
10.40 Bonus Session; Reserved For Exclusive Conference Partner
11.10 Morning Refreshment Break With Informal Networking
TRUST, PERCEPTION & MISINFORMATION
PANEL Q&A
11.50 Explore Communication Strategies That Build Trust, Shape Perception, Dispel Misinformation & Foster Meaningful Relationships
- Leverage new strategies to craft compelling narratives that successfully combat misinformation while remaining compliant, ultimately strengthening trust with the public and critical stakeholders
- Decode the dynamics of public perception and identify potential reputation risks with actionable strategies to unlock credibility-enhancing opportunities in an environment of increasing scepticism
- Effectively address sensitive topics with innovative strategies to reshape perception and create impactful messages which resonate
Rebuild trust in an era of uncertainty and unpredictability by deploying strategies to combat misinformation and foster stronger relationships with both patients and the media
Andy Collier, Senior Policy Manager – Reputation, ABPI
Diana Scholz, Head Of Global Communications, Consumer Health, Bayer
Mary Hinks-Edwards, Communications & Government Affairs Director, European Partnership Markets, GSK
Yasmin Ghariani, Head Of External Communications, Chiesi UK
Thomas Hutter, Associate Director Commercial Communications, International, CSL Vifor
CHANGING GEOPOLITICS
FIRESIDE CHAT
12.20 Navigate Geopolitical Shifts: Explore Agile Communications Strategies To Protect Reputation, Trust & Resilience In Times Of Volatility
- How are geopolitical shifts and global health disruptions shaping pharma communications? Examine strategies to navigate geopolitical complexity while safeguarding brand integrity and trust
- Tackle the impact of geopolitical changes and budget changes or uncertainty to ensure your company remains resilient and innovative in an increasingly volatile environment
- Address the complexities of supply chain disruptions and regulatory uncertainty by crafting impactful communication strategies that communicate risks and keep stakeholders informed
Justine Hibbert Boone, Head Of Global Public Health Communications, Roche
Nicole Seroff, VP, Head Of Corporate Communications & Executive Office, Bavarian Nordic
ETHICS, REGULATORY COMPLIANCE & POLICY SPOTLIGHT
12.40 Operating Within Compliance, Navigate The Changing Regulatory Landscape Through Collaboration, Leveraging Evolving Tech & Ethical Decision-Making
- Innovate within regulatory constraints, balancing creative messaging with accuracy, while adapting content to stay compliant with shifting regulations
- Unlock the power of early collaboration and discover how aligning regulatory, legal, and compliance teams from the start can streamline processes, reduce risk, and ensure all content is in line with ever-evolving guidelines
- How is AI and automation reshaping compliance? From content screening to risk flagging, discover practical approaches for embedding AI in your processes without losing nuance or accountability
- Transform your decision-making process by examining how integrating ethical principles into compliance strategies ensures your communications remain both compliant and ethically responsible, even in uncertain landscapes
PATIENT ENGAGEMENT CASE STUDY
13.00 Exclusive Sanofi Case Study
Kersten Sharrock, Global Head, Integrated Patient Engagement, Sanofi Corporate Public Affairs, Sanofi
13.20 Lunch & Informal Networking For Speakers, Delegates & Partners
13.50 Breakout Sessions
A) Rare Diseases
Victoria Hayes, Director Of Public Affairs, Northern Cluster (UK, Ireland, Nordics & Baltics), Kyowa Kirin International plc.
B) Internal Comms
C) Strategic External Partnerships
OPENING REMARKS
14.20 Afternoon Co-Chairs’ Opening Remarks
Andy McGuffie, Government Affairs & Policy Director, Global Vaccines, GSK
Pia Beltrão Hansen, Director Of Commercial & Product Communications, Ascendis Pharma
PATIENT ENGAGEMENT & INCLUSION
PANEL Q&A
14.30 Revolutionise Patient Engagement, Build Authentic Connections, Foster Meaningful Dialogue & Ensure Equitable Access Across Global Markets
- How are you scaling patient engagement and disease awareness campaigns across diverse markets? Develop strategies to build authentic, lasting connections with patient communities globally
- Explore ways to include patient voices and foster ongoing, meaningful dialogue that builds trust and delivers lasting, mutual value
- Employ AI responsibly: ensure tools are trained on representative data and respect cultural nuance to ultimately enhance patient engagement
- Tackle the evolving challenges in DEI and maintain your commitment to diverse representation and equitable access as essential foundations of credible patient engagement
Stephen Cull, Global Assoc. Director, Obesity Communications, Novo Nordisk
Stephanie Ribbe, Executive Director Communications & Patient Advocacy Europe, Novartis
Carla Martinez, Associate Director Of External Corporate Communications, Almirall
Lisa Timothy, External Affairs Director, UK & Ireland, Takeda
Victoria Hayes, Director Of Public Affairs, Northern Cluster (UK, Ireland, Nordics & Baltics), Kyowa Kirin International plc.
SUSTAINABILITY & ESG VALUE IN HEALTHCARE
FIRESIDE CHAT
15.00 Elevate Pharma’s Credibility & Social Value By Embedding Robust ESG & Sustainability Strategies Into Healthcare Communications
- Embed ESG into your organisational DNA by aligning sustainability with legal, compliance, and governance teams to ensure credibility, consistency, and long-term accountability
- Leverage data analytics to track environmental impact, support robust reporting, and power smarter, greener decisions
- What makes a net-zero pledge credible, and how can you avoid greenwashing by aligning global commitments with local action?
- Uncover new ways to demonstrate social value by showing how your medicines reduce long-term healthcare costs, improve public health outcomes, and position your organisation as a responsible healthcare leader
Marina Konrad-Maerk, Global Director Communications, Sandoz
Chiara Montecucco, Corporate and Sustainability Communication Lead, UCB
15.20 Bonus Session; Reserved For Exclusive Conference Partner
15.50 Afternoon Refreshment Break With Informal Networking
DATA & MEASUREMENT
PROVEN IMPACT
16.20 Build A Wider Understanding Of The Work ‘Impact’ In Publications Across The Industry By Unlocking The Full Potential Of Our Data – A Call To Action For Stakeholders
- Tackle the challenge of misinformation by establishing clear, measurable indicators of success and impact to better guide future strategies
- What metrics matter, why do they matter and what else do we want to know and why?
- How do we all work together to make a metric that can become an industry standard?
James Dathan, Associate Director, BBU Publications & Evidence Communications Lead, AstraZeneca
SOCIAL MEDIA & CHANGING LANDSCAPES
PANEL Q&A
16.40 Leverage The Power Of Social Media To Build Trust, Engage Authentically & Strengthen Your Reputation In Unpredictable Digital Spaces
- In an environment of polarised digital spaces, harness social platforms to open dialogue, share accurate information and foster understanding to enhance public trust
- Navigate emerging voices, such as healthcare influencers, to engage and inform new demographics around health and healthcare
- Explore the boundaries of digital innovation and regulatory compliance to humanise pharma communications, foster meaningful engagement, and build trust in the spotlight of social media scrutiny
- Elevate social media as a strategic communications tool by aligning channel strategy with audience behaviours to deliver credible, values-driven messaging that integrates with your corporate narrative and stakeholder engagement
Karen Borrer, Head Of Communications UK & Ireland, UCB
Pia Beltrão Hansen, Director Of Commercial & Product Communications, Ascendis Pharma
Lorenzo Ciapinna, Senior Director Medical Information & Communication International, Incyte
Syeda Hasnain, Head of Communications UKIE, Merck Healthcare
CUTTING-EDGE DIGITAL COMMS
17.00 Harness Next-Gen Digital Communications To Deepen Engagement & Deliver Targeted & Meaningful Impact Across Channels
- Explore the impact of channel diversity to truly uncover the unique digital platforms your audience engages with and how to tailor your messaging across each, ultimately enhancing reach and fostering deeper connections with patients, carers, and HCPs
- Leverage brand new digital tools! Streamline delivery to ensure targeted messaging that aligns with patient preferences and ultimately help your messages cut through the digital noise, creating a more direct, meaningful impact
- Enhance patient engagement through digital strategies grounded in user behaviour insights, enabling more effective, relevant communication and improving trust
17.20 Afternoon Co-Chairs’ Closing Remarks & Close Of Conference
Andy McGuffie, Government Affairs & Policy Director, Global Vaccines, GSK
Pia Beltrão Hansen, Director Of Commercial & Product Communications, Ascendis Pharma
